Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Meridian Bioscience Receives FDA Clearance For New Rapid Campylobacter Test
Meridian Bioscience, Inc. (NASDAQ: VIVO) announced that it has received FDA clearance from the U.S. Food and Drug Administration (FDA) for a new rapid test for Campylobacter, ImmunoCard STAT!® CAMPY. This new test provides fast and accurate detection of Campylobacter bacteria, one of the most common causes of diarrheal illness and the most common bacterial cause of foodborne illness in the United States. Approximately 20 million stool culture tests are conducted each year in the U.S. to detect the illness, known as Campylobacteriosis. Campylobacter is most often transmitted by poorly cooked poultry or person-to-person contact.
generic viagra online
Previously Confidential Study Results Released On Amputee Sprinter Oscar Pistorius
A team of experts in biomechanics and physiology that conducted experiments on Oscar Pistorius, the South African bilateral amputee track athlete, have just published their findings in the Journal of Applied Physiology. Some of their previously confidential findings were presented to the Court of Arbitration for Sport (CAS) in Lausanne, Switzerland in May of 2008. Other findings are now being released for the first time.
News of the day
PinPointe™ FootLaser™ Submits Its Breakthrough Laser Treatment For Toenail Fungus To Health Canada For Approval
PinPointe FootLaser announced it has submitted its innovative new laser treatment for toenail fungus (Onychomycosis) to Health Canada for approval. As the Federal department responsible for helping Canadians maintain and improve their health, Health Canada reviews medical devices to assess their safety, effectiveness and quality before being authorized for sale in Canada. PinPointe FootLaser has been awarded the CE Mark certifying it has met European Union consumer health and safety standards, has been cleared for use in the treatment of toenail fungus in the EU, and can be offered by healthcare providers throughout Europe. Additionally, the treatment is FDA cleared for applications in dermatology, plastic surgery, and podiatry in the United States.
Endocrinology

Different s In Adolescent Prescription Drug Misuse May Indicate Likelihood Of Concurrent Substance Abuse

The misuse of prescription medications by adolescents is surpassed only by illicit use of alcohol, tobacco, and marijuana. A study to be published in the August 2009 issue of the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP) shows that how an adolescent obtains these prescription drugs may signal the likelihood that an adolescent will be concurrently abusing another substance and the severity of substance abuse and prescription misuse. Drs. Ty Schepis and Suchitra Krishnan-Sarin at the Yale University School of Medicine used data from the 2005 and 2006 National Survey on Drug Use and Health (NSDUH), to show that across all classes of medications (opioids, stimulants, tranquilizers, and sedatives) nearly 50 percent were obtained from friends or families for free. With the exception of opioids, the second most common was by purchasing the drug from friends or relatives (13.1% - 29.7%) or from a drug dealer (4.6% - 12.0%). For opioids, the second most common was from a physician. The misuse of opioids, stimulants, tranquilizers, and sedatives poses significant risk for physical and/or psychological dependence as well as overdose. In the article titled, "s of Prescriptions for Misuse by Adolescents: Differences in Sex, Ethnicity, and Severity of Misuse in a Population-Based Study," the authors used regression analyses, to offer "̣€¦preliminary evidence that the group with greatest odds of concurrent other substance use may be those who purchased their medication for misuse from friends, family or drug dealers. In comparisons with adolescents who misused medication obtained from a physician, adolescents who buy medication are more likely to have endorsed binge alcohol use (opioids and tranquilizers), daily cigarette use (opioids and stimulants), past month marijuana use (all three classes examined), and past year cocaine use (opioids and stimulants)." Addressing the concern of identifying at risk youths, Schepis said, "In addition to assessing whether or not child and adolescent patients are misusing addictive prescription medications, it also appears important for clinicians to assess how these medications are obtained. Such information may help determine which patients are most likely to have substance use problems or depressive symptoms." Follow up data from the 2007 National Survey on Drug Use and Health (NSDUH), shows that among persons aged 12 or older in 2007 who used pain relievers nonmedically in the past 12 months, 56.5 percent got the pain relievers they most recently used from a friend or relative for free. Another 8.9 percent bought them from a friend or relative, and 5.2 percent reported stealing them from a friend or relative. Nearly one fifth (18.1 percent) indicated that they got the drugs from one doctor. Around 1 in 20 users (4.1 percent) got pain relievers from a drug dealer or other stranger, and 0.5 percent said they bought them on the Internet. The National Survey on Drug Use and Health (NSDUH) is conducted by Substance Abuse and Mental Health Services Administration (SAMHSA) under the Department of Health and Human Services and provides national and state-level data on the use of illicit and non-medical prescription drugs in the United States on an annual basis. The study findings by Drs. Schepis and Krishnan-Sarin were supported in part by National Institutes of Health grant T32-DA007238. The National Survey on Drug Use and Health is sponsored by the Substance Abuse and Mental Health Services Administration. The study is published in the Journal of the American Academy of Child and Adolescent Psychiatry and online. References Schepis TS, Krishnan-Sarin S. s of Prescriptions for Misuse by Adolescents: Differences in Sex, Ethnicity, and Severity of Misuse in a Population-Based Study. Journal of the American Academy of Child and Adolescent Psychiatry. 2009; 48: 828-836. Substance Abuse and Mental Health Services Administration, Office of Applied Studies (2008). Results from the 2007 National Survey on Drug Use and Health: National Findings (NSDUH Series H-34, DHHS Publication No. SMA 08-4343). Rockville, MD. The Journal of the American Academy of Child and Adolescent Psychiatry


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009